RETROVIR, a drug licensed in Britain for treating people with AIDS or
other symptoms of infection with HIV, may soon be available for treating
people with HIV who have shown no sign of illness. The Wellcome Foundation,
the British pharmaceuticals company, announced this week that it had won
provisional clearance from the Committee for Proprietary Medicinal Products
of the European Commission to seek wider use for Retrovir. Individual member
states of the EC are now considering the committee’s recommendations.
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Autism may have two distinct subtypes that vary by brain activity
2
A quantum state that lasts forever may finally be within our grasp
3
Sperm have been made magnetic to allow IVF inside the body
4
The secrets to keeping your brain sharp in old age
5
Fully autonomous drones have killed human soldiers for the first time
6
Walking shark found in Papua New Guinea is new to science
7
Global map reveals the vast scale of underground fungal networks
8
Arctic Ocean reaches tipping point that could be dire for marine life
9
What if the idea of the autism spectrum is completely wrong?
10
Vaping after quitting smoking is linked to lung cancer
